Johnson & Johnson Remains an Innovation Powerhouse
Image Source: Johnson & Johnson By Brian Nelson, CFA Johnson & Johnson (JNJ) recently reported first quarter results that showed revenue and non-GAAP earnings per share exceeding the consensus forecast. First quarter reported sales growth was 2.4%, with operational growth of 4.2% and adjusted operational growth of 3.3%. First quarter earnings per share increased to $4.54, while adjusted earnings per share advanced 2.2%, to $2.77. Management had the following to say about the results: The power of Johnson & Johnson’s uniquely diversified portfolio was on full display this quarter, with strong operational sales growth reinforcing our confidence in 2025 guidance. During the quarter, we fortified our position as an innovation powerhouse with major advancements across our pipeline, including TREMFYA in … Read more